PTGX — Protagonist Therapeutics, Inc. stock price, charts and financials

QT62Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
135.81
+3.53+2.67%
OverviewShort InterestFilings
PTGXQT62Protagonist Therapeutics, Inc.·NASDAQ
135.81+2.67%
TA
Loading chart...
Short Interest History· Twice monthly
Settlement DateShort InterestAvg Daily VolumeShares FloatShort Float %Short Ratio
Jul-15-268.29M717.09K52.49M15.80%11.56
Jun-30-267.69M696.24K52.49M14.65%11.05
Jun-15-267.73M718.00K52.49M14.72%10.76
May-29-267.41M730.49K52.49M14.12%10.14
May-15-267.29M746.69K52.49M13.89%9.77
Apr-30-267.54M766.43K52.49M14.37%9.84
Apr-15-268.40M789.31K52.49M16.00%10.64
Mar-31-268.63M811.50K52.49M16.43%10.63
Mar-13-268.06M761.64K52.49M15.36%10.58
Feb-27-268.19M811.50K52.49M15.61%10.10
Feb-13-268.44M850.65K52.49M16.09%9.93
Jan-30-268.13M903.49K52.49M15.49%9.00